What is the CBAN stock price forecast for 2026-2027?
The 2 Wall Street analysts covering Colony Bankcorp, Inc. have a median 12-month price target of $25, with estimates ranging from $24 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is CBAN stock a buy right now?
Of the 2 analysts covering Colony Bankcorp, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Colony Bankcorp, Inc. 61 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank CBAN?
As at 2 Sept 2026, Colony Bankcorp, Inc. ranks 61 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (88 of 100).
Will CBAN stock go up?
No one can know that. What the data says: the median 12-month target from 2 analysts implies +16.2% from the last close, and Ticker Nerd's factor model ranks Colony Bankcorp, Inc. 61 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the CBAN stock forecast for 2030?
No analyst covering Colony Bankcorp, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CBAN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $24 to $26 over the next 12 months.
How has CBAN stock performed over the past year?
Colony Bankcorp, Inc. returned +29.5% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Colony Bankcorp, Inc. do?
Colony Bankcorp, Inc. is a bank holding company that operates through its subsidiary, Colony Bank, providing a broad range of banking services to retail, commercial, and small business customers.
What is the latest news on CBAN?
The most recent item we track (Business Wire, 1 Sept 2026): "First Reliance Bancshares Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of First Reliance Bancshares, Inc. - FSRL". Law firm Kahn Swick & Foti, led by former Louisiana Attorney General Charles Foti, announced an investigation into the adequacy of the price and process in the proposed sale of First Reliance Bancshares to Colony Bankcorp. Under the deal terms, First Reliance shareholders would receive $19.75 in cash or 0.94 of a Colony common share per share.